Literature DB >> 20548328

High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues.

M J Sikora1, J N Thibert, J Salter, M Dowsett, M D Johnson, J M Rae.   

Abstract

Single-nucleotide polymorphisms (SNPs) can be assayed using DNA isolated from archival formalin-fixed, paraffin-embedded (FFPE) samples, making retrospective pharmacogenetic studies possible. In this study, we describe methods that significantly increase the number of SNP determinations possible using FFPE samples. Quantifying the amount of DNA amenable to PCR (amplification-quality DNA, AQ-DNA) allows a significant reduction in the amount of sample required for Taqman-based SNP assays. Optimizing AQ-DNA input increases PCR amplification efficiency and SNP determination accuracy. DNA was extracted from 39 FFPE tumor sections and matched tumor and stromal cores, which were of the type used to generate tissue microarrays. Sections and tumor cores yielded sufficient AQ-DNA for more than 1000 SNP determinations. Seven SNPs were assessed following individual assay optimization for minimal AQ-DNA. Genotypes from tumor cores for single SNPs were 92.3-100% concordant with those obtained from sections. Using these methods, the number of SNP genotypes that can be determined from single FFPE samples is greatly increased expanding the genetic association studies possible from limited archival specimens. The use of tumor cores is of particular importance as the harvesting of tumor cores has minimal impact on the utility of the donor blocks for other purposes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20548328      PMCID: PMC2996486          DOI: 10.1038/tpj.2010.50

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  27 in total

1.  An efficient method for the assessment of DNA quality of archival microdissected specimens.

Authors:  Arek Siwoski; Adrian Ishkanian; Cathie Garnis; Lewei Zhang; Miriam Rosin; Wan L Lam
Journal:  Mod Pathol       Date:  2002-08       Impact factor: 7.842

2.  Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.

Authors:  Helene Nortvig Abrahamsen; Torben Steiniche; Ebba Nexo; Stephen J Hamilton-Dutoit; Boe Sandahl Sorensen
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

3.  The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.

Authors:  A Gaedigk; S D Simon; R E Pearce; L D Bradford; M J Kennedy; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

4.  Concordance of pharmacogenetic markers in germline and colorectal tumor DNA.

Authors:  Sharon Marsh; Mary Ann Mallon; Paul Goodfellow; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2005-12       Impact factor: 2.533

5.  The applicability of formalin-fixed and formalin fixed paraffin embedded tissues in forensic DNA analysis.

Authors:  R L Romero; A C Juston; J Ballantyne; B E Henry
Journal:  J Forensic Sci       Date:  1997-07       Impact factor: 1.832

6.  Real-time quantitative RT-PCR shows variable, assay-dependent sensitivity to formalin fixation: implications for direct comparison of transcript levels in paraffin-embedded tissues.

Authors:  Ina Koch; Julia Slotta-Huspenina; Regina Hollweck; Natasa Anastasov; Heinz Hofler; Leticia Quintanilla-Martinez; Falko Fend
Journal:  Diagn Mol Pathol       Date:  2006-09

7.  Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes.

Authors:  Bryan P Schneider; Todd C Skaar; George W Sledge; Sunil Badve; Lang Li; David A Flockhart
Journal:  Breast Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.872

8.  Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material.

Authors:  C N Andreassen; F B Sørensen; J Overgaard; J Alsner
Journal:  Radiother Oncol       Date:  2004-09       Impact factor: 6.280

9.  A multiplex PCR predictor for aCGH success of FFPE samples.

Authors:  E H van Beers; S A Joosse; M J Ligtenberg; R Fles; F B L Hogervorst; S Verhoef; P M Nederlof
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

10.  Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer.

Authors:  R Mort; L Mo; C McEwan; D W Melton
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more
  11 in total

1.  Genotyping concordance in DNA extracted from formalin-fixed paraffin embedded (FFPE) breast tumor and whole blood for pharmacogenetic analyses.

Authors:  Daniel L Hertz; Kelley M Kidwell; Jacklyn N Thibert; Christina Gersch; Meredith M Regan; Todd C Skaar; N Lynn Henry; Daniel F Hayes; Catherine H Van Poznak; James M Rae
Journal:  Mol Oncol       Date:  2015-07-29       Impact factor: 6.603

2.  Concordance of DNA methylation profiles between breast core biopsy and surgical excision specimens containing ductal carcinoma in situ (DCIS).

Authors:  Youdinghuan Chen; Jonathan D Marotti; Erik G Jenson; Tracy L Onega; Kevin C Johnson; Brock C Christensen
Journal:  Exp Mol Pathol       Date:  2017-07-12       Impact factor: 3.362

3.  Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2.

Authors:  Esther Lopez-Rivera; Padmini Jayaraman; Falguni Parikh; Michael A Davies; Suhendan Ekmekcioglu; Sudeh Izadmehr; Denái R Milton; Jerry E Chipuk; Elizabeth A Grimm; Yeriel Estrada; Julio Aguirre-Ghiso; Andrew G Sikora
Journal:  Cancer Res       Date:  2014-01-07       Impact factor: 12.701

4.  DNA and RNA analysis of blood and muscle from bodies with variable postmortem intervals.

Authors:  Jakob Hansen; Iana Lesnikova; Anette Mariane Daa Funder; Jytte Banner
Journal:  Forensic Sci Med Pathol       Date:  2014-06-10       Impact factor: 2.007

Review 5.  Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.

Authors:  George Miles; James Rae; Suresh S Ramalingam; John Pfeifer
Journal:  Semin Oncol       Date:  2015-07-14       Impact factor: 4.929

6.  CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.

Authors:  Meredith M Regan; Brian Leyland-Jones; Mark Bouzyk; Olivia Pagani; Weining Tang; Roswitha Kammler; Patrizia Dell'orto; Maria Olivia Biasi; Beat Thürlimann; Maria B Lyng; Henrik J Ditzel; Patrick Neven; Marc Debled; Rudolf Maibach; Karen N Price; Richard D Gelber; Alan S Coates; Aron Goldhirsch; James M Rae; Giuseppe Viale
Journal:  J Natl Cancer Inst       Date:  2012-03-06       Impact factor: 13.506

7.  Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.

Authors:  Lauren A Marcath; Kelley M Kidwell; Kiran Vangipuram; Christina L Gersch; James M Rae; Monika L Burness; Jennifer J Griggs; Catherine Van Poznak; Daniel F Hayes; Ellen M Lavoie Smith; N Lynn Henry; Andreas S Beutler; Daniel L Hertz
Journal:  Br J Clin Pharmacol       Date:  2020-02-04       Impact factor: 4.335

8.  CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.

Authors:  James M Rae; Suzy Drury; Daniel F Hayes; Vered Stearns; Jacklyn N Thibert; Ben P Haynes; Janine Salter; Ivana Sestak; Jack Cuzick; Mitch Dowsett
Journal:  J Natl Cancer Inst       Date:  2012-03-06       Impact factor: 13.506

9.  Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.

Authors:  Catherine Van Poznak; Evan L Reynolds; Cherry L Estilo; Mimi Hu; Bryan Paul Schneider; Daniel L Hertz; Christina Gersch; Jacklyn Thibert; Dafydd Thomas; Mousumi Banerjee; James M Rae; Daniel F Hayes
Journal:  Oral Dis       Date:  2020-12-14       Impact factor: 3.511

10.  High quality and quantity Genome-wide germline genotypes from FFPE normal tissue.

Authors:  Lisa A Cannon-Albright; Kendal G Cooper; Ann Georgelas; Philip S Bernard
Journal:  BMC Res Notes       Date:  2011-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.